Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice

Brain Research

Volumn 808, Issue 2, 1998, Pages 166-173

  Gelot, Agathe ^a   Francés, Bernard ^a   Roussin, Anne ^a   Latapie, Jean Philippe ^a   Zajac, Jean Marie ^a  

^a CNRS   (France)

Author keywords

Analgesia; Anti opioid; Morphine; Mouse; Neuropeptide FF; Tolerance

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE FF;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HOT PLATE TEST; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANIMALS; ANTIBODIES; DRUG TOLERANCE; HEAT; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NARCOTIC ANTAGONISTS; NARCOTICS; NEUROPEPTIDES; NOCICEPTORS; OLFACTORY BULB; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; RECEPTORS, NEUROPEPTIDE; REFLEX; SPINAL CORD;

EID: 0032547888     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00665-9     Document Type: Article

References (50)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res. 500:1989;169-176.
2. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunohistochemical studies. Neuroscience. 40:1991;81-92.
3. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116.
4. Archer T., Jonsson G., Minor B.G., Post C. Noradrenergic-serotoninergic interactions and nociception in the rat. Eur. J. Pharmacol. 120:1986;295-307.
5. Baber N.G., Dourish C.T., Hill D.R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain. 39:1989;307-308.
6. Barbaz B.S., Hall N.R., Liebman J.M. Antagonism of morphine analgesia by CCK-8-S does not extend to all assays nor all opiate analgesics. Peptides. 9:1989;1295-1300.
7. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
8. Danneman P.J. Monitoring of analgesia. Anesth. Analg. 6:1997;83-103.
9. Derrien M., Noble F., Maldonado R., Roques B.P. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot-plate test in mice. Neurosci. Lett. 160:1993;193-196.
10. Desprat C., Zajac J.-M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
11. Desprat C., Zajac J.M. Differential modulation of μ- and ∂-opioid antinociception by neuropeptide FF receptors in young mice. Neuropeptides. 31:1997;1-7.
12. Dewey W.L., Snyder J.W., Harris L.S., Howes J.F. The effects of narcotics and narcotic antagonists on the tail-flick response in spinal mice. J. Pharm. Pharmacol. 21:1969;548-550.
13. Dupouy V., Zajac J.-M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul. Pept. 59:1995;349-356.
14. 3] NPFF Synapse. 24:1996;282-296.
15. Gear R.W., Levine J.D. Antinociception produced by an ascending spino-supraspinal pathway. J. Neurosci. 15:1995;3154-3161.
16. Gelot A., Fioramonti J., Zajac J.-M., Bueno L. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats. Neuropeptides. 29:1995;245-250.
17. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
18. Gicquel S., Fioramonti J., Bueno L., Zajac J.-M. Effects of F8Famide analogs on intestinal transit in mice. Peptides. 14:1993;749-753.
19. Gouardères C., Sutak M., Zajac J.-M., Jhamandas K. Antinociceptive effect of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
20. Gouardères C., Jhamandas K., Sutak M., Zajac J.-M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
21. 3]NPFF Brain Res. Bull. 42:1997;231-238.
22. Haley T.J., McCormick W.G. Pharmacological effects produced by intra-cerebral injection of drugs in conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
23. Illich P.A., King T.A., Grau J.W. Impact of shock on pain reactivity: I. Whether hypo- or hyper-algesia is observed depends on how pain reactivity is tested. J. Exp. Psychol. Anim. Behav. Process. 21:1995;331-347.
24. Irwin S., Houde R.W., Bennett D.R., Hendershot L.C., Seevers M.H. The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther. 101:1951;132-143.
25. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
26. King T.E., Joynes R.L., Mengher M.W., Grau J.W. Impact of shock on pain reactivity: II. Evidence for enhanced pain. J. Exp. Psychol. Anim. Behav. Process. 22:1996;265-278.
27. King T.E., Joynes R.L., Grau J.W. Tail-flick test: II. The role of supraspinal systems and avoidance learning. Behav. Neurosci. 111:1997;754-767.
28. Kivipelto L., Majane E.A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
29. Kivipelto L., Panula P. Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain. Neuroscience. 41:1991;137-148.
30. Kivipelto L., Panula P. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J. Comp. Neurol. 307:1991;107-119.
31. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.-Y.T., Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132:1991;29-32.
32. Lake J.R., Hebert K.M., Payza K., Deshotel K.D., Hausam D.D., Witherspoon W.E., Acangeli K.R., Malin D.H. Analogs of neuropeptide FF attenuates morphine tolerance. Neurosci. Lett. 146:1992;203-206.
33. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99.
34. 2-like peptide. Brain Res. 494:1989;1-12.
35. 2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
36. 2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
37. Malin D.H., Lake J.R., Leyva J.E., Hammond M.V., Rogillio R.B., Archangeli K.R., Ludgate K., Moore G.M., Payza K. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides. 12:1991;1011-1014.
38. Malin D.H., Lake J.R., Arcangeli K.R., Deshotel K.D., Hausam D.D., Witherspoon W.E., Carter V.A., Yang H.-Y.T., Pal B., Burgess K. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci. 53:1993;261-266.
39. Malin D.H., Lake J.R., Smith D.A., Jones J.A., Morel J., Claunch A.E., Stevens P.A., Payza K., Ho K.K., Liu J.et al. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug Alcohol Dep. 40:1995;37-42.
40. Narita M., Takahashi Y., Takamori K., Funada M., Suzuki T., Misawa M., Nagase H. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn. J. Pharmacol. 62:1993;15-24.
41. Noble F., Derrien M., Roques B.P. Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain. Br. J. Pharmacol. 109:1993;1064-1070.
42. Noble F., Smadja C., Roques B.P. Role of endogenous cholecystokinin in the facilitation of Mu-mediated antinociception by Delta-opioid agonists. J. Pharmacol. Exp. Ther. 271:1994;1127-1134.
43. Oberling P., Stinus L., Le Moal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of Neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
44. 2), inhibit colonic bead expulsion time in mice. Peptides. 10:1989;873-875.
45. Rezayat M., Nikfar S., Zarrindast M.-R. CCK receptor activation may prevent tolerance to morphine in mice. Eur. J. Pharmacol. 254:1994;21-26.
46. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
47. Schmauss C., Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception: II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther. 228:1984;1-12.
48. Stinus L., Allard M., Gold L., Simonnet G. Change in CNS Neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides. 16:1995;1235-1241.
49. 2-like immunoreactivity. Proc. Natl. Acad. Sci. U.S.A. 81:1984;5002-5005.
50. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U.S.A. 82:1985;7757-7761.